Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -34.42%-1.19B | -448.66%-1.39B | -151.10%-882.92M | 269.58%398.1M | -5.15%1.73B | -103.08%-234.76M | -57.41%1.82B | -26.44%7.62B | 17.61%4.28B | 4.72%10.36B |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---4.58M |
| Attributable subsidiary (profit) loss | 240.69%97.46M | 78.50%-198.24M | 91.20%-69.27M | -6.36%-922.15M | -210.95%-787.16M | -12.49%-866.99M | 49.54%-253.15M | 20.13%-770.76M | -4.57%-501.66M | 21.84%-965.03M |
| Impairment and provisions: | 18.19%1.04B | -39.94%2.01B | 15.37%879.09M | 55.78%3.35B | 123.36%761.99M | 184.39%2.15B | 313.73%341.15M | 136.83%756.59M | -63.93%82.46M | 112.80%319.47M |
| -Impairment of property, plant and equipment (reversal) | 30.76%1.15B | -24.72%1.51B | 6.81%882.85M | 76.55%2.01B | 124.23%826.58M | 55.64%1.14B | 218.53%368.64M | 99.74%731.13M | -51.88%115.73M | 63.68%366.05M |
| -Other impairments and provisions | -2,969.66%-115.33M | -62.73%500.52M | 94.18%-3.76M | 32.46%1.34B | -135.03%-64.6M | 3,880.45%1.01B | 17.40%-27.48M | 154.67%25.47M | -179.67%-33.27M | 36.64%-46.58M |
| Revaluation surplus: | 1,633.08%67.28M | -389.17%-288.7M | -68.32%3.88M | -42.40%99.84M | -91.58%12.26M | -37.07%173.32M | 183.88%145.52M | 579.54%275.43M | 356.88%51.26M | -33.65%-57.44M |
| -Fair value of investment properties (increase) | 1.63%75.76M | 17.05%120.06M | 389.99%74.54M | 1,194.98%102.58M | -28.82%15.21M | 108.18%7.92M | 134.87%21.37M | -9.56%-96.81M | -48.85%-61.29M | -77.24%-88.37M |
| -Derivative financial instruments fair value (increase) | 88.09%-8.22M | ---406.49M | ---69.02M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other fair value changes | 84.00%-262K | 17.00%-2.27M | 44.62%-1.64M | -101.65%-2.74M | -102.38%-2.96M | -55.57%165.4M | 10.30%124.15M | 1,103.52%372.24M | 430.37%112.55M | 349.55%30.93M |
| Asset sale loss (gain): | 17.10%725.09M | 238.78%1.01B | 682.34%619.2M | 238.22%296.84M | 123.35%79.15M | 61.27%-214.75M | -179,239.68%-338.95M | -177.19%-554.43M | 99.61%-189K | -4,864.38%-200.02M |
| -Loss (gain) from sale of subsidiary company | 17.08%725.09M | 321.76%521.63M | 678.93%619.32M | 144.08%123.68M | 123.46%79.51M | 31.11%-280.56M | -179,239.68%-338.95M | -103.61%-407.24M | 99.61%-189K | -4,864.38%-200.02M |
| -Loss (gain) on sale of property, machinery and equipment | 96.61%-4K | 117.09%81K | 67.40%-118K | 50.31%-474K | ---362K | ---954K | ---- | ---- | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | 178.70%483.91M | ---- | 160.05%173.63M | ---- | 145.36%66.77M | ---- | ---147.19M | ---- | ---- |
| Depreciation and amortization: | -59.00%9.9M | -81.01%15.34M | -57.63%24.14M | -5.14%80.8M | 37.06%56.99M | -5.24%85.18M | -19.61%41.58M | -18.76%89.89M | -11.94%51.72M | 50.25%110.64M |
| -Amortization of intangible assets | -75.85%1.19M | -92.20%771K | 0.08%4.93M | 0.20%9.88M | 106.54%4.93M | 125.14%9.86M | 11.44%2.39M | 35.24%4.38M | 46.54%2.14M | 310.39%3.24M |
| Financial expense | 183.39%396.5M | 107.53%644.37M | -30.69%139.91M | -21.83%310.49M | -6.97%201.88M | -38.66%397.18M | 4.60%217.01M | 19.35%647.46M | 5.59%207.48M | 16.28%542.49M |
| Exchange Loss (gain) | -147.17%-27.88M | -60.54%69.59M | -81.92%59.1M | -70.18%176.38M | -8.57%326.86M | 340.39%591.42M | 604.05%357.51M | ---246.02M | ---70.93M | ---- |
| Special items | -294.37%-1.76B | -704.22%-593.24M | -1,016.93%-446.8M | 70.59%-73.77M | 48.83%-40M | 30.22%-250.82M | 58.15%-78.18M | 21.62%-359.43M | -17.46%-186.82M | 11.07%-458.56M |
| Adjustment items | ---- | ---- | ---- | --50K | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | -296.57%-641.47M | -65.59%1.28B | -86.05%326.33M | 103.03%3.72B | 3.80%2.34B | -75.46%1.83B | -42.36%2.25B | -22.68%7.46B | 14.56%3.91B | 9.79%9.65B |
| Change of operating capital | ||||||||||
| Developing property (increase)decrease | -73.44%4.71B | -6.85%35.68B | 45.62%17.71B | 169.77%38.3B | 47.52%12.16B | 1,497.77%14.2B | 189.85%8.25B | 103.22%888.56M | 33.06%-9.18B | 2.68%-27.62B |
| Accounts receivable (increase)decrease | 14.00%-983K | -3,707.55%-4.04M | 72.18%-1.14M | 95.78%-106K | -290.59%-4.11M | -8,273.33%-2.51M | -519.12%-1.05M | -100.06%-30K | 107.69%251K | 37,378.46%48.72M |
| Accounts payable increase (decrease) | -439.25%-2.93B | -66.84%1.23B | -132.89%-542.63M | 354.63%3.71B | 1.63%1.65B | -93.40%815.05M | -79.08%1.62B | -33.43%12.35B | 5.48%7.76B | 241.26%18.55B |
| prepayments (increase)decrease | -405.19%-787.14M | -376.59%-5.75B | 520.43%257.92M | 175.67%2.08B | 96.42%-61.35M | 38.72%-2.75B | 73.25%-1.72B | 2.73%-4.48B | 6.07%-6.41B | 74.52%-4.61B |
| Special items for working capital changes | 94.33%-1.09B | 30.27%-34.65B | -40.55%-19.17B | -2,953.95%-49.69B | -901.96%-13.64B | -129.38%-1.63B | -115.28%-1.36B | -56.48%5.54B | 62.26%8.91B | -31.98%12.73B |
| Cash from business operations | 48.11%-737.71M | -17.12%-2.21B | -158.16%-1.42B | -115.17%-1.89B | -72.97%2.44B | -42.70%12.47B | 81.08%9.04B | 148.74%21.76B | 216.80%4.99B | 164.65%8.75B |
| Other taxs | 118.71%79.5M | -33.53%-501.88M | -64.02%-424.97M | 78.68%-375.86M | 81.74%-259.11M | 58.49%-1.76B | 52.36%-1.42B | -21.67%-4.25B | -45.39%-2.98B | 1.34%-3.49B |
| Interest received - operating | -48.86%10.11M | -59.52%29.14M | -50.64%19.77M | -70.29%71.97M | -49.51%40.04M | -17.38%242.23M | -59.16%79.3M | -28.22%293.17M | 22.09%194.19M | -10.90%408.45M |
| Net cash from operations | 64.53%-648.1M | -22.44%-2.69B | -182.09%-1.83B | -120.05%-2.19B | -71.11%2.23B | -38.51%10.95B | 248.62%7.7B | 214.25%17.81B | 135.84%2.21B | 127.87%5.67B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 234.99%68.07M | -28.50%714.47M | -93.95%20.32M | 91.39%999.31M | --335.73M | --522.14M | ---- | ---- | ---- | ---- |
| Loan receivable (increase) decrease | 38.37%788.46M | -64.42%768.17M | 87.45%569.84M | 339.18%2.16B | 151.14%303.99M | 53.05%-902.57M | 80.95%-594.42M | 51.61%-1.92B | -119.78%-3.12B | -1,102.10%-3.97B |
| Sale of fixed assets | -99.00%4K | -88.69%96K | -13.92%402K | -60.68%849K | -45.82%467K | -35.99%2.16M | 61.42%862K | 23.19%3.37M | -96.34%534K | --2.74M |
| Purchase of fixed assets | 88.65%-180K | -114.39%-11.26M | -60.85%-1.59M | 22.57%-5.25M | 68.55%-986K | 72.42%-6.78M | 70.39%-3.14M | 56.25%-24.6M | -16.69%-10.59M | -14.48%-56.22M |
| Purchase of intangible assets | 93.36%-370K | 93.19%-397K | -64.71%-5.57M | 34.72%-5.83M | -359.02%-3.38M | -328.21%-8.92M | 35.18%-737K | 41.97%-2.08M | -2,319.15%-1.14M | 57.56%-3.59M |
| Sale of subsidiaries | -1,812.13%-26.33M | 97.45%-2.6M | 98.28%-1.38M | -155.56%-101.74M | -198.72%-79.95M | -24.83%183.12M | -60.30%80.99M | 120.18%243.61M | 441.53%204.01M | -276.25%-1.21B |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---113.44M | ---- | ---- | ---- | ---- | ---- | 2,066.19%382.07M |
| Recovery of cash from investments | -82.82%20.24M | 385.44%817.69M | -75.72%117.78M | -86.86%168.44M | 56.26%485.09M | 65.99%1.28B | 14,509.18%310.45M | 564.56%772.43M | --2.13M | 17,836.88%116.23M |
| Cash on investment | -424.09%-80.86M | 78.80%-105.88M | 95.78%-15.43M | 30.46%-499.33M | -38.88%-365.36M | 86.34%-718.08M | 89.98%-263.07M | 38.60%-5.26B | 53.01%-2.62B | -70.84%-8.56B |
| Other items in the investment business | 468.04%367.87M | 430.32%1.34B | --64.76M | -71.52%253.08M | ---- | --888.77M | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 51.76%1.14B | 23.38%3.52B | 10.88%749.14M | 129.87%2.85B | 244.03%675.6M | 120.08%1.24B | 91.55%-469.07M | 53.49%-6.19B | 21.39%-5.55B | -165.35%-13.3B |
| Net cash before financing | 145.35%488.8M | 26.51%835.14M | -137.15%-1.08B | -94.58%660.16M | -59.90%2.9B | 4.91%12.19B | 316.64%7.24B | 252.20%11.62B | 74.75%-3.34B | 69.88%-7.63B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -24.61%273.9M | -38.36%1.55B | -85.44%363.3M | -70.94%2.52B | -36.14%2.5B | -78.07%8.67B | -87.28%3.91B | -26.28%39.53B | -12.76%30.72B | -2.28%53.62B |
| Refund | 18.38%-963.6M | 41.71%-5.59B | 82.79%-1.18B | 58.65%-9.59B | 48.25%-6.86B | 56.37%-23.2B | 51.54%-13.26B | -46.46%-53.17B | -22.03%-27.35B | 11.78%-36.3B |
| Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 17.31%7.52B | 38.57%4.82B | 56.52%6.41B |
| Interest paid - financing | 7.44%-183.47M | 44.22%-364.5M | 72.81%-198.21M | 57.01%-653.51M | 49.71%-728.94M | 65.19%-1.52B | 44.35%-1.45B | 16.42%-4.37B | -54.23%-2.6B | ---5.23B |
| Dividends paid - financing | -163.34%-266.83M | -110.69%-145.91M | -45.58%-101.32M | 86.90%-69.25M | 57.21%-69.6M | 56.14%-528.47M | ---162.63M | 22.92%-1.2B | ---- | -216.22%-1.56B |
| Absorb investment income | -38.30%83.56M | -57.00%175.85M | --135.43M | -18.92%408.99M | ---- | -80.51%504.44M | -96.32%88.33M | -37.15%2.59B | -30.45%2.4B | -27.26%4.12B |
| Issuance expenses and redemption of securities expenses | ---- | ---65.77M | ---65.77M | ---- | ---- | 84.68%-1.22B | 62.13%-1.22B | -506.34%-7.98B | ---3.23B | -1,106.72%-1.32B |
| Pledged bank deposit (increase) decrease | ---- | ---- | ---- | ---- | ---- | 472.07%500M | -44.83%500M | 90.61%-134.38M | 527.52%906.35M | -1,642.17%-1.43B |
| Other items of the financing business | -1,934.41%-75.15M | 86.72%-78.67M | 47.20%-3.69M | 43.04%-592.24M | ---7M | ---1.04B | ---- | ---- | ---- | --317.17M |
| Net cash from financing operations | -7.47%-1.13B | 43.63%-4.52B | 79.79%-1.05B | 55.12%-8.03B | 55.18%-5.21B | -3.51%-17.88B | -306.22%-11.62B | -193.03%-17.27B | -68.34%5.64B | -27.90%18.57B |
| Effect of rate | 232.73%183K | 67.77%203K | -46.60%55K | -99.07%121K | 100.79%103K | -48.38%13.06M | -6,555.67%-13.11M | 20.82%25.3M | -95.25%203K | 485.72%20.94M |
| Net Cash | 69.82%-643.07M | 49.92%-3.69B | 7.70%-2.13B | -29.43%-7.37B | 47.40%-2.31B | -0.63%-5.69B | -291.06%-4.39B | -151.72%-5.65B | -49.84%2.3B | 2,568.89%10.93B |
| Begining period cash | -50.95%3.55B | -50.43%7.24B | -50.43%7.24B | -27.99%14.6B | -27.99%14.6B | -21.73%20.28B | -21.73%20.28B | 73.25%25.91B | 73.25%25.91B | 2.78%14.96B |
| Cash at the end | -43.07%2.91B | -50.95%3.55B | -58.46%5.11B | -50.43%7.24B | -22.57%12.3B | -27.99%14.6B | -43.71%15.88B | -21.73%20.28B | 44.36%28.21B | 73.25%25.91B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | --16.59B | ---- | ---- | 1.47%35.54B | ---- |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | --16.59B | ---- | ---- | 1.47%35.54B | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Ernst & Young Accounting Firm | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.